- Home
- JCSE vs SILO Comparison
JCSE vs SILO Comparison
Compare JCSE & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- SILO
- Stock Information
- Founded
- JCSE 1999
- SILO 2010
- Country
- JCSE Singapore
- SILO United States
- Employees
- JCSE N/A
- SILO N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- SILO Apparel
- Sector
- JCSE Consumer Discretionary
- SILO Consumer Discretionary
- Exchange
- JCSE Nasdaq
- SILO Nasdaq
- Market Cap
- JCSE 7.6M
- SILO 8.8M
- IPO Year
- JCSE 2022
- SILO N/A
- Fundamental
- Price
- JCSE $1.55
- SILO $1.35
- Analyst Decision
- JCSE
- SILO
- Analyst Count
- JCSE 0
- SILO 0
- Target Price
- JCSE N/A
- SILO N/A
- AVG Volume (30 Days)
- JCSE 14.9K
- SILO 228.4K
- Earning Date
- JCSE 10-30-2024
- SILO 03-04-2025
- Dividend Yield
- JCSE 5.81%
- SILO N/A
- EPS Growth
- JCSE N/A
- SILO N/A
- EPS
- JCSE 0.12
- SILO N/A
- Revenue
- JCSE $14,723,999.00
- SILO $72,102.00
- Revenue This Year
- JCSE N/A
- SILO $1.86
- Revenue Next Year
- JCSE N/A
- SILO N/A
- P/E Ratio
- JCSE $12.55
- SILO N/A
- Revenue Growth
- JCSE N/A
- SILO N/A
- 52 Week Low
- JCSE $0.64
- SILO $0.77
- 52 Week High
- JCSE $2.39
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- JCSE 53.49
- SILO 40.14
- Support Level
- JCSE $1.42
- SILO $1.39
- Resistance Level
- JCSE $1.71
- SILO $1.52
- Average True Range (ATR)
- JCSE 0.08
- SILO 0.14
- MACD
- JCSE -0.02
- SILO -0.05
- Stochastic Oscillator
- JCSE 44.83
- SILO 0.97
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.